Role and regulation of convergent antisense transcription by RNA polymerase II
Role and regulation of convergent antisense transcription by RNA polymerase II
批准号:
418415292
负责人:
Dr. Andreas Mayer
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2019
资助国家:
德国
项目状态:
已结题
起止时间:
2018-12-31 至 2021-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Gene transcription by RNA polymerase II (Pol II) is not a unidirectional process. Transcription in the sense direction is usually accompanied by antisense transcription in the opposite orientation. Antisense transcription is emerging as a new layer in regulating the expression of the sense gene. We have recently developed native elongating transcript sequencing (NET-seq) as a quantitative genome-wide approach for studying the full spectrum of sense and antisense transcription with nucleotide precision in human cells (Mayer et al., Cell, 2015; Mayer et al., Nat Protocols, 2016). Application of this high-resolution method has revealed a new antisense transcriptional activity of Pol II in the promoter-proximal region of a large set of protein-coding and long non-coding RNA genes, called convergent antisense transcription. Convergent antisense transcription predominantly occurs at lower expressed genes and inversely correlates with sense transcription suggesting a potential regulatory link. However, key aspects of convergent antisense transcription remain undefined. Here, we propose to address two fundamental questions: (1) What molecular mechanisms drive this antisense transcriptional activity? (2) What is the functional role of convergent antisense transcription in controlling the transcriptional output of cells? To understand the determinants and functions of convergent antisense transcription in human cells, we will employ an interdisciplinary combination of high-resolution genome-wide approaches, genome editing tools and single-molecule microscopy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anthropology of the Intangible.Human Gesture as an Object of the Modern Human Sciences
-
批准号:238473441
-
项目类别:Heisenberg Fellowships
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Dr. Andreas Mayer
-
依托单位:
Elucidate the functions of the BET bromodomain protein BRD4 in co-transcriptional splicing
-
批准号:498442505
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Dr. Andreas Mayer
-
依托单位:
Mechanisms of transcription elongation control by the biomolecular condensate forming BET family protein BRD4
-
批准号:539611427
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Dr. Andreas Mayer
-
依托单位:
国内基金
海外基金
登录
查看更多内容
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
精氨酸调控骨髓Tregs稳态在脓毒症骨髓功能障碍中的作用研究
-
批准号:82371770
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:宁铂涛
-
依托单位:
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
-
批准号:82371801
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:周海波
-
依托单位:
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
-
批准号:82371028
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵慧
-
依托单位:
亚低温调控颅脑创伤急性期神经干细胞Mpc2/Lactate/H3K9lac通路促进神经修复的研究
-
批准号:82371379
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:冯军峰
-
依托单位:
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
-
批准号:82372275
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘耀宝
-
依托单位:
α-酮戊二酸调控ACMSD介导犬尿氨酸通路代谢重编程在年龄相关性听力损失中的作用及机制研究
-
批准号:82371150
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯书乐
-
依托单位:
mPFC-VTA-NAc多巴胺能投射调控丙泊酚麻醉—觉醒的机制研究
-
批准号:82371284
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:许涛
-
依托单位: